Delivery — actually getting RNA into cells — has long bedeviled the whole field. On their own, RNA molecules have a hard time reaching their targets. They work better if they’re wrapped up in a delivery mechanism, such as nanoparticles made of lipids. But those nanoparticles can lead to dangerous side effects, especially if a patient has to take repeated doses over months or years. Novartis abandoned the related realm of RNA interference over concerns about toxicity, as did Merck and Roche.
Methinks graphene oxide
Graphene Oxide Nanosheets Interact and Interfere with SARS‐CoV‐2 Surface Proteins and Cell Receptors to Inhibit Infectivity nih.gov ^ | June 24, 2021 | Mehmet Altay Unal, 1 Fatma Bayrakdar, 2 Hasan Nazir, 3 Omur Besbinar, 1 , 4 Cansu Gurcan, 1 , 4 Neus Posted on 8/1/2021, 9:21:43 AM by ransomnote
Graphene oxide toxicity Graphene toxicity Graphene oxide is not stable in physiological solutions and shows dose-dependent in vitro toxicity, as well as in vivo lung accumulation and pulmonary toxicity. PEGylated nano-graphene exhibits dramatically improved biocompatibility and is found to be less toxic in vitro and in vivo . Graphene in Biomedicine: Opportunities and Challenges www.medscape.com/viewarticle/738857_5
Today, La Quinta Columna has made an urgent announcement that they hope will reach as many people as possible, especially those involved in health and legal services, as biostatistician Ricardo Delgado, Dr. José Luis Sevillano and the team of researchers and professors with whom they have been conducting their research have confirmed the presence of graphene oxide nanoparticles in vaccination vials.